14.02.2020 Xlife Sciences AG  CH0461929603

DGAP-Adhoc: Xlife Sciences AG: Capital Increase 'Private Placement'


 

DGAP-Ad-hoc: Xlife Sciences AG / Key word(s): Capital Increase
Xlife Sciences AG: Capital Increase 'Private Placement'

14-Feb-2020 / 14:14 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Xlife Sciences AG: Capital Increase 'Private Placement'

Based on the resolution of the Board of Directors on 14th of February 2020 (resolution of the general assembly on 25th of October 2018), Xlife Sciences AG has decided to execute a "private placement" from authorized capital, 260'000 shares at a share price of CHF 33.50.- (EUR 30.70.-, average share price over the 30 last trading days, EUR/CHF average rate ESTV 1.0912). Xlife Sciences AG will direct more investments towards employees in research and development. In addition, the project portfolio will be further diversified.

Xlife Sciences AG

Xlife Sciences AG is a Swiss company with focus on investing in promising technologies in the life science industry. Xlife Sciences AG is building the bridge from research and development to healthcare markets by supporting researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. Together with industrial partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development of innovative and future-oriented technologies at a very early stage.
For more information, please visit: www.xlifesciences.ch


14-Feb-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Xlife Sciences AG
Klausstrasse 19
8008 Zürich
Switzerland
Phone: 0041 44 385 84 60
E-mail: [email protected]
Internet: www.xlifesciences.ch
ISIN: CH0461929603
WKN: A2PK6Z
Listed: Regulated Unofficial Market in Munich
EQS News ID: 975861

 
End of Announcement DGAP News Service

975861  14-Feb-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=975861&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,47 0,37 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 -0,69 -2,80 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 -146,81 -756,76 0,00 0,00
EBIT1,4 0,00 0,00 0,00 -0,71 -2,85 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 -151,06 -770,27 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,95 19,46 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 202,13 5.259,46 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 -0,37 -0,37 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,27 3,60 7,00 12,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,50 1,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Baker Tilly

FWB:XLS Charts by TradingView (c)


INVESTOR-INFORMATIONEN
©boersengefluester.de
Xlife Sciences
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2PK6Z 46,200 233,74
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
7,11 7,93 0,90 10,77
KBV KCV KUV EV/EBITDA
1,95 - 638,63 -99,36
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,50 1,08 11.05.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
24.08.2021 26.04.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,48% -3,35% 5,00% -5,71%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Xlife Sciences AG  ISIN: CH0461929603 können Sie bei DGAP abrufen


Beteiligungen , A2PK6Z , XLS , FWB:XLS